BIO · ASX

Biome Australia Ltd (ASX:BIO)

AU$0.65

 -0.02 (-2.985%)
ASX:Live
15/11/2024 04:10:48 PM
HALO Price Momentum HALO Ords HALO Momentum HALO Growth HALO Earnings Momentum +4
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

BIO Overview

BIO Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Strong

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Strong

About BIO

Website

N/A

Telephone

61.3.9017.5800

Address

192-194 Johnston Street Collingwood, Victoria (VIC) 3066

Description

Biome Australia Ltd. engages in the research, development, manufacture, and distribution of evidence-based products linking the gut and human health. It offers live biotherapeutics products and complementary medicines under the Activated Probiotic brand. The company was founded by Blair Vega Norfolk on July 6, 2018 and is headquartered in Collingwood, Australia.

BIO Price Chart

Key Stats

Market Cap

AU$146.81M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.11 - 0.87

Trade Value (12mth)

AU$85,844.00

1 week

2.29%

1 month

0%

YTD

191.3%

1 year

482.61%

All time high

0.87

Key Fundamentals

EPS 3 yr Growth

-70.30%

EBITDA Margin

-12.90%

Operating Cashflow

$0m

Free Cash Flow Return

-4.30%

ROIC

-44.10%

Interest Coverage

-10.10

Quick Ratio

1.10

Other Data

Shares on Issue (Fully Dilluted)

215m

HALO Sector

Healthcare

Next Company Report Date

29-Jul-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.04

BIO Announcements

Latest Announcements

Date Announcements

14 November 24

Biome Strain Development Program Success

×

Biome Strain Development Program Success

13 November 24

Business and International Market Update

×

Business and International Market Update

24 October 24

Quarterly Activities & Cashflow Report

×

Quarterly Activities & Cashflow Report

11 October 24

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

11 October 24

Letter to Shareholders with Respect to Notice of Meeting

×

Letter to Shareholders with Respect to Notice of Meeting

01 October 24

Record quarterly sales revenue for Q1

×

Record quarterly sales revenue for Q1

30 September 24

Vision 27 Strategic Plan Presentation

×

Vision 27 Strategic Plan Presentation

30 September 24

Vision 27 Video Presentation

×

Vision 27 Video Presentation

25 September 24

Annual Report

×

Annual Report

25 September 24

Appendix 4G & Corporate Governance Statement

×

Appendix 4G & Corporate Governance Statement

19 September 24

Biome Commences Test Market In Canada

×

Biome Commences Test Market In Canada

17 September 24

Date of AGM and Closing Date for Director Nominations

×

Date of AGM and Closing Date for Director Nominations

10 September 24

Application for quotation of securities - BIO

×

Application for quotation of securities - BIO

10 September 24

Secondary Trading Notice

×

Secondary Trading Notice

04 September 24

FY24 Overview Investor Webinar Recording

×

FY24 Overview Investor Webinar Recording

03 September 24

Q1 FY25 Revenue Guidance

×

Q1 FY25 Revenue Guidance

26 August 24

Preliminary Final Report

×

Preliminary Final Report

26 August 24

Financial Year 2024 Key Results

×

Financial Year 2024 Key Results

26 August 24

Amended Preliminary Financial Report

×

Amended Preliminary Financial Report

26 August 24

Investor Webinar

×

Investor Webinar

26 August 24

Company Presentation

×

Company Presentation

19 August 24

Clinically Proven Cholesterol Reducing Probiotic Launched

×

Clinically Proven Cholesterol Reducing Probiotic Launched

29 July 24

Biome shares three-year revenue target

×

Biome shares three-year revenue target

15 July 24

Quarterly Activities & Cashflow Report

×

Quarterly Activities & Cashflow Report

05 July 24

Application for quotation of securities - BIO

×

Application for quotation of securities - BIO

BIO Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.02 -0.02 -0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.02 -0.02 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 15.6 32.6 47.7 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.02 -0.01 -0.00 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.02 -0.02 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock -54.5 21.5 62.6 Lock Lock Lock
     Yield % Lock Lock Lock Lock -23.7 -27.0 -0.2 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.03 0.02 0.01 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.03 0.02 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 312.9 -45.6 -24.0 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 200 201 208 Lock Lock Lock
Basic m Lock Lock Lock Lock 200 201 208 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 4 7 13 Lock Lock Lock
     Growth % Lock Lock Lock Lock 77.8 75.5 79.8 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 7 7 10 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 2 4 8 Lock Lock Lock
     Growth % Lock Lock Lock Lock 114.9 76.0 89.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock 55.9 56.0 59.0 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 44 44 41 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -4 -3 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 23.5 26.2 45.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -100.5 -42.3 -12.9 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -4 -3 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 23.5 22.5 41.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -102.5 -45.3 -14.7 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -5 -3 -2 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -5 -3 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 15.6 32.2 45.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -110.1 -42.5 -12.8 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -3 -3 0 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 8 1 1 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -4 -4 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock -44.2 -9.8 95.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.9 -0.5 -0.0 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 6 2 3 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 8 8 8 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 1 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -5 -1 -2 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 2 4 5 Lock Lock Lock
Equity $m Lock Lock Lock Lock 7 4 3 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 7 5 3 Lock Lock Lock
     Growth % Lock Lock Lock Lock 319.5 -34.7 -31.9 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -55.0 -40.7 -20.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -69.6 -85.8 -57.5 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -97.7 -55.9 -42.8 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -106.3 -54.0 -44.1 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -80.1 -61.3 -4.3 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock -126.3 -97.7 -10.1 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 1.2 0.4 0.9 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -77.9 -31.1 -54.1 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 5.7 2.3 1.5 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 4.7 1.3 1.1 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 72.6 33.4 37.2 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -253.2 -117.1 -3.2 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 5.4 6.5 6.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 1.6 1.5 2.2 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.7 1.9 5.1 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 27.3 31.4 19.2 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.5 1.0 1.6 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.5 1.0 1.6 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -115.6 -47.1 -15.3 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -57.7 -45.1 -24.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -55.0 -40.7 -20.2 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.3 2.1 2.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -69.6 -85.8 -57.5 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -69.6 -85.8 -57.5 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 232.9 248.0 167.8 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 67.9 56.4 60.5 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 300.7 304.4 228.3 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 151.8 126.6 206.8 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 149.0 177.8 21.5 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.04%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

BIO Shortsell

Frequently Asked Questions

The current share price of Biome Australia Ltd (BIO:ASX) is AU$0.65.
The 52-week high share price for Biome Australia Ltd (BIO:ASX) is AU$0.87.
The 52-week low share price for Biome Australia Ltd (BIO:ASX)? is AU$0.11.
Biome Australia Ltd (BIO:ASX) does not pay a dividend.
Biome Australia Ltd (BIO:ASX) does not pay a dividend.
Biome Australia Ltd (BIO:ASX) has a franking level of 0.0%.
Biome Australia Ltd (BIO:ASX) is classified in the Healthcare.
The current P/E ratio for Biome Australia Ltd (BIO:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.